"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
 
           
          Annexin VPI法为什么凋亡结果与预期不符?
处理时间过长,处理浓度过高,细胞初始活性差等原因导致的假阳性或假阴性结果。